K. Mitra

Arjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies

M. Doble, S. Gummadi, G. Rajaraman, 2021, Journal of biomolecular structure & dynamics.

Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.

V. Ulaganathan, R. Lotha, Vaidehi Tiru, 2018, Microbial pathogenesis.

Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads

M. Doble, P. Ghanta, B. Ramaiah, 2020, Journal of biomolecular structure & dynamics.

Self-Assembled Inhalable Immunomodulatory Silk Fibroin Nanocarriers for Enhanced Drug Loading and Intracellular Antibacterial Activity.

M. Doble, A. Chadha, V. Muthuvijayan, 2022, ACS biomaterials science & engineering.

Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)—A cell division protein

M. Doble, Kartik Mitra, G. Chakrapani, 2020, PloS one.

Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study.

M. Doble, A. Chadha, K. Mitra, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Preparation of Curdlan sulphate - Chitosan nanoparticles as a drug carrier to target Mycobacterium smegmatis infected macrophages.

M. Doble, S. Arumugam, Kartik Mitra, 2021, Carbohydrate polymers.

Potential of Terminalia Arjuna as a Promising PhytoremedyAgainst COVID-19: DPPH Scavenging, Catalase Inhibition and Molecular Docking Studies

M. Doble, S. Arumugam, S. Dash, 2020 .

Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies.

P. Shukla, K. Mitra, Devendra Kumar, 2012, International journal of pharmaceutics.

Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein

M. Doble, J. Selvaraj, Medha Pandya, 2022, BMC Bioinform..